Disc Medicine, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
Disc Medicine, Inc. (IRON) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 8.18 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-02-26
- Disc Medicine, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-12-31 was 88.00 shares, a 99.88% decline year-over-year.
- Disc Medicine, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-09-30 was 712.00 shares.
- Disc Medicine, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-06-30 was 10.71K shares.
- Disc Medicine, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-03-31 was 1.24K shares.
- Disc Medicine, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 8.18K shares, a 35.88% decline from fiscal 2024.
- Disc Medicine, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 12.75K shares, a 91.05% decline from fiscal 2023.
- Disc Medicine, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 142.45K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2025-12-31 | 8.18K shares 10-K · filed 2026-02-26 | |||
| 2024-12-31 | 88.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 800.00 shares derived: sum of 2 quarters · filed 2025-02-27 | 11.51K shares derived: sum of 3 quarters · filed 2025-02-27 | 12.75K shares 10-K · filed 2025-02-27 |
| 2024-09-30 | 712.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 11.42K shares derived: sum of 2 quarters · filed 2024-11-12 | 12.66K shares 10-Q · filed 2024-11-12 | 84.69K shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 10.71K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 11.95K shares 10-Q · filed 2024-08-08 | 83.97K shares derived: sum of 3 quarters · filed 2024-08-08 | |
| 2024-03-31 | 1.24K shares 10-Q · filed 2024-05-09 | 73.27K shares derived: sum of 2 quarters · filed 2024-05-09 | ||
| 2023-12-31 | 72.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | 142.45K shares 10-K · filed 2024-03-21 | ||
| 2023-09-30 | 70.43K shares 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |